Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PTPN1 | P18031 | 4/20 | 0.51 |
| ▸ | HPGD | P15428 | 1/20 | 0.48 |
| ▸ | LGALS9 | O00182 | 1/20 | 0.47 |
| ▸ | LGALS1 | P09382 | 1/20 | 0.47 |
| ▸ | LGALS3 | P17931 | 1/20 | 0.47 |
| ▸ | PTPN2 | P17706 | 1/20 | 0.46 |
| ▸ | PTPN11 | Q06124 | 1/20 | 0.46 |
| ▸ | USP2 | O75604 | 2/20 | 0.43 |
| ▸ | MEN1 | O00255 | 1/20 | 0.43 |
| ▸ | POLB | P06746 | 1/20 | 0.43 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.43 |
| ▸ | F11 | P03951 | 2/20 | 0.41 |
| ▸ | TMPRSS2 | O15393 | 1/20 | 0.41 |
| ▸ | PDE5A | O76074 | 1/20 | 0.41 |
| ▸ | CA1 | P00915 | 1/20 | 0.41 |
| ▸ | CA2 | P00918 | 1/20 | 0.41 |
| ▸ | HMGCR | P04035 | 1/20 | 0.41 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.41 |
| ▸ | LCK | P06239 | 1/20 | 0.41 |
| ▸ | FYN | P06241 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18279683 | 1.00 | PTPN1 (0.51) | PTPN1HPGDLGALS9LGALS1LGALS3 | |
| SCHEMBL2493931 | 0.86 | USP2 (0.55) | PTPN1LGALS9LGALS1LGALS3PTPN2 | |
| SCHEMBL5707687 | 0.86 | USP2 (0.55) | PTPN1LGALS9LGALS1LGALS3PTPN2 | |
| SCHEMBL3496162 | 0.86 | USP2 (0.55) | PTPN1LGALS9LGALS1LGALS3PTPN2 | |
| SCHEMBL11726595 | 0.86 | USP2 (0.55) | PTPN1LGALS9LGALS1LGALS3PTPN2 | |
| SCHEMBL2493929 | 0.86 | USP2 (0.55) | PTPN1LGALS9LGALS1LGALS3PTPN2 | |
| SCHEMBL26801670 | 0.86 | USP2 (0.55) | PTPN1LGALS9LGALS1LGALS3PTPN2 | |
| SCHEMBL11061066 | 0.86 | USP2 (0.55) | PTPN1LGALS9LGALS1LGALS3PTPN2 | |
| SCHEMBL14274463 | 0.86 | USP2 (0.55) | PTPN1LGALS9LGALS1LGALS3PTPN2 | |
| SCHEMBL14010241 | 0.85 | PTPN1 (0.69) | PTPN1HPGDLGALS9LGALS1LGALS3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9884882-B2 | Method for producing thiolane skeleton-type glycoconjugate, and thiolane skeleton-type glycoconjugate | FUJIFILM CORPORATION (JP) | 2018-02-06 | — | — | US | disclosed |
| US-9884882-B2 | Method for producing thiolane skeleton-type glycoconjugate, and thiolane skeleton-type glycoconjugate | FUJIFILM CORPORATION (JP) | 2018-02-06 | — | — | US | disclosed |
| EP-3109245-B1 | METHOD FOR PRODUCTING THIOLANE SKELETON-TYPE GLYCOCONJUGATE, AND THIOLANE SKELETON-TYPE GLYCOCONJUGATE | FUJIFILM CORP (JP) | 2018-01-03 | — | — | EP | disclosed |
| EP-3109245-A1 | METHOD FOR PRODUCTING THIOLANE SKELETON-TYPE GLYCOCONJUGATE, AND THIOLANE SKELETON-TYPE GLYCOCONJUGATE | FUJIFILM Corporation (JP) | 2016-12-28 | — | — | EP | disclosed |
| US-20160355536-A1 | METHOD FOR PRODUCING THIOLANE SKELETON-TYPE GLYCOCONJUGATE, AND THIOLANE SKELETON-TYPE GLYCOCONJUGATE | FUJIFILM CORPORATION (JP) | 2016-12-08 | — | — | US | disclosed |
| US-20160355536-A1 | METHOD FOR PRODUCING THIOLANE SKELETON-TYPE GLYCOCONJUGATE, AND THIOLANE SKELETON-TYPE GLYCOCONJUGATE | FUJIFILM CORPORATION (JP) | 2016-12-08 | — | — | US | disclosed |
| US-20160355536-A1 | METHOD FOR PRODUCING THIOLANE SKELETON-TYPE GLYCOCONJUGATE, AND THIOLANE SKELETON-TYPE GLYCOCONJUGATE | FUJIFILM CORPORATION (JP) | 2016-12-08 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160355536-A1 | METHOD FOR PRODUCING THIOLANE SKELETON-TYPE GLYCOCONJUGATE, AND THIOLANE SKELETON-TYPE GLYCOCONJUGATE | ST6GAL1, FUT6, FUT5 | PTPN1 2033/4885HPGD 1321/4885LGALS9 388/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.